
gastroparesis
Takeda, Altos Therapeutics To Develop Gastroparesis Treatment
The partnership will develop Altos’s proprietary compound ATC-1906 to address the symptoms of nausea and vomiting in gastroparesis patients.

The partnership will develop Altos’s proprietary compound ATC-1906 to address the symptoms of nausea and vomiting in gastroparesis patients.